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Abstract 
The EQ-5D is made up of health state dimensions and levels, where some combinations seem less 
 “ƉůĂƵƐŝďůĞ ?ƚŚĂŶŽƚŚĞƌƐ ?/Ĩ “ŝŵƉůĂƵƐŝďůĞ ?ƐƚĂƚĞƐĂƌĞƵƐĚŝŶŚĞĂůƚŚƐƚĂƚĞǀĂůƵĂƚŝŽŶĞǆĞƌĐŝƐĞƐ ?ƚŚĞŶ
respondents may have difficulty imagining them, causing measurement error.  There is currently no 
standard solution: some valuation studies exclude such states, whilst others leave them in.  This study 
aims to address two gaps in the literature: (1) to propose an evidence-based set of the least prevalent 
two-way combinations of EQ-5D-5L dimension-levels; and (2) to quantify the impact of removing 
perceived implausible states from valuation designs. For the first aim, we use data from two waves of 
the English General Practitioner Patient Survey (n=1,639,453).  For the second aim, we re-model a 
secondary dataset of a Discrete Choice Experiment (DCE) with duration that valued EQ-5D-5L and 
compare across models that drop observations involving different health states: (i) implausible states as 
defined in the literature; (ii) the least prevalent states identified in stage (1); and (iii) randomly select 
states; alongside (iv) a model that does not drop any observations. The results indicate that two-way 
combinations previously thought to be implausible actually exist amongst the general population; there 
are other combinations that are rarer; and that removing implausible states from an experimental 
design of a DCE with duration leads to value sets with potentially different characteristics depending on 
the criterion of implausible states.  We advise against the routine removal of implausible states from 
health state valuation studies. 
[243wds] 
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1. Introduction  
 
Preference-based generic health instruments are used to operationalise the Quality Adjusted Life Year 
(QALY) for the economic evaluation of health care interventions. Typically, they take the form of a 
descriptive or classification system, made up of dimensions of health with differing levels of severity that 
describe different health states; and an accompanying value set, or tariff, which specifies the preference 
weights for each of the health states that the classification system describes on an interval scale with 1 
for full health and 0 for being dead.  Examples of such instruments include the EQ-5D-3L1 and EQ-5D-5L,2 
HUI3,3 SF-6D,4 and AQoL.5 For example, EQ-5D-3L has five dimensions: mobility (MO), self-care (SC), 
usual activities (UA), pain or discomfort (PD), and anxiety or depression (AD); with three severity levels 
across each (1 for no problems and 3 for the most severe), thus distinguishing 243 different health 
states.6 EQ-5D-5L is a later variant with five levels instead of three, distinguishing 3,125 different health 
states.7 
 
The value sets are typically estimated by health state valuation studies that survey members of the 
ƉƵďůŝĐĨŽƌƚŚĞŝƌƉƌĞĨĞƌĞŶĐĞƐĨŽƌƐƚǇůŝƐĞĚŚĞĂůƚŚƐƚĂƚĞĚĞƐĐƌŝƉƚŝŽŶƐ ?ŽĨƚĞŶƌĞĨĞƌƌĞĚƚŽĂƐ “ŚǇƉŽƚŚĞƚŝĐĂů
ŚĞĂůƚŚƐƚĂƚĞƐ ? ?ƐĞůĞĐƚĞĚĨƌŽŵƚŚĞĚĞƐĐƌŝƉƚŝǀĞƐǇƐƚĞŵ ?dŚĞƐĞǀĂůƵĂƚŝŽŶĚĂƚĂĂƌĞƚŚĞŶ modelled 
econometrically, to predict average preferences for all health states described by the classification 
system. One potential consideration in the selection of the stylised health states is their plausibility. The 
ŝĚĞĂŽĨ “ŝŵƉůĂƵƐŝďůĞƐƚĂƚĞƐ ?ĐĂŶďe broken down into two.  One is where some health states appear 
unlikely and more difficult for a typical general public respondent to imagine (difficult-to-imagine 
states).  The other is where some states are, as a matter of fact, much less prevalent than others (rare 
states).  The extreme case of the latter are states that will never be observed (impossible states), but 
since self-reporting of states involves error, it is futile to distinguish empirically between rare states and 
impossible states. A given health state may be both difficult-to-imagine and rare. However, for the 
purpose of selecting the stylised health states for valuation, what matters are the difficult-to-imagine 
states, as perceived by survey respondents.   
 
The Measurement and Valuation of Health (MVH) project is one of the earliest examples of a health 
state valuation study, and used the time trade-off (TTO) method to value EQ-5D-3L states.8 When 
selecting the 42 EQ- ?ƐƚĂƚĞƐƚŚĂƚǁĞƌĞǀĂůƵĞĚ ?ƚŚĞƌĞƐĞĂƌĐŚĞƌƐ “ǁĂŶƚĞĚƚŽĞǆĐůƵĚĞƐƚĂƚĞƐǁŚich 
ƐĞĞŵĞĚƉƌŝŵĂĨĂĐŝĞŝŵƉůĂƵƐŝďůĞƚŽƌĞƐƉŽŶĚĞŶƚƐ ?ƐŽĂƐƚŽƐƵƐƚĂŝŶŵŽƚŝǀĂƚŝŽŶĂŶĚĐƌĞĚŝďŝůŝƚǇ ? ?8 Thus, they 
excluded states that combine no problems in one dimension and an extreme problem in another 
 ?ŚĞƌĞĂĨƚĞƌ ? “ƚǁŽ-ǁĂǇĐŽŶƚƌĂƐƚŝŶŐĐŽŵďŝŶĂƚŝŽŶƐ ? ? ?ƐƉĞĐŝĨically, between no problems in usual activities 
ĂŶĚ PĞǆƚƌĞŵĞƉƌŽďůĞŵƐŝŶŵŽďŝůŝƚǇ ?ĚĞƐĐƌŝďĞĚĂƐďĞŝŶŐ ?ĐŽŶĨŝŶĞĚƚŽďĞĚ ? ?h ?ǆDK ? ? ?ŽƌĞǆƚƌĞŵĞ
problems in self-care (UA1xSC3).1  However, there was no empirical basis to select these combinations. 
 
The methodological literature on health state valuation since then has largely left this topic untouched, 
ĂŶĚƐƚƵĚŝĞƐŚĂǀĞĞŝƚŚĞƌĞǆĐůƵĚĞĚ ?Žƌ “ďĂĐŬĞĚŽĨĨ ?ĨƌŽŵ ?ŚĞĂůƚŚƐƚĂƚĞƐĐŽŶƐŝĚĞƌĞĚƚŽďĞŝŵƉůĂƵƐŝďůĞ
albeit without empirical support (e.g. Viney et al.9), or have included all possible combinations in the 
design development process (e.g. Mulhern et al.10). Where health states are selected through any 
experimental design procedure, simply dropping certain states may result in inefficiency (error) and/or 
inaccuracy (bias). However, if those states are difficult for respondents to imagine, then keeping them in 
the design may also result in measurement error introducing error and/or bias. The exception is the 
Australian EQ-5D-3L valuation study using a Discrete Choice Experiment (DCE), which included a 
simulation exercise where the effect of removing certain states was examined.11 A design with all 
possible EQ-5D-3L states was compared to a design that dropped 45 states judged to be implausible - 
this time defined as two-way contrasting combinations of the worst severity level in mobility with: 
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either no problems in usual activity (MO3xUA1), or with no problems in self-care (MO3xSC1)9. The 
findings suggested the variability in data was greater in the all-states design, but the statistical efficiency 
was lower in the design where these perceived implausible states were dropped. However, as the 
authors state, the exercise only examined the efficiency of designs, and not the measurement error 
attributable to the difficulty of imagining these states. In a separate study, Jakubczyk and Golicki12 
applied an experimental TTO design to examine the amount of imprecision around health preferences 
from a Polish student sample. The authors found that values of states with two-way contrasting 
combinations have higher imprecision and that imprecision is mostly driven by UA and AD. 
 
The aims of this study were to first analyse the prevalence of self-reported EQ-5D-5L states in a large 
sample of the general population, in order to propose an evidence-based set of the least prevalent EQ-
5D-5L states. Second, to re-model a rich secondary DCE-with-duration health state valuation dataset to 
quantify the impact of excluding choice sets that involve health states that we find the least prevalent.  
This is compared against models that remove health states considered implausible by existing literature 
and a model that does not drop any observations.  In order to distinguish between the effect of 
removing specific states and the effect of removing any states, we also have a series of models that 
remove choice sets at random. 
 
 
2. Methods 
 
2.1 Stage 1: Prevalence of EQ-5D-5L states in the general population 
For the first stage, self-reported EQ-5D-5L data from the General Practitioner (GP) Patient Survey were 
used.  This is a large cross-ƐĞĐƚŝŽŶĂůƐƵƌǀĞǇĐŽŶĚƵĐƚĞĚďǇE,^ŶŐůĂŶĚ ? “ĚĞƐŝŐŶĞĚƚŽŐŝǀĞƉĂƚŝĞŶƚƐƚŚĞ
ŽƉƉŽƌƚƵŶŝƚǇƚŽĨĞĞĚďĂĐŬĂďŽƵƚƚŚĞŝƌĞǆƉĞƌŝĞŶĐĞƐŽĨƚŚĞŝƌ'WƉƌĂĐƚŝĐĞ ? ?13 The sample consists of 
individuals aged 18 or above with a valid National Health Service (NHS) number, who have been 
registered with a GP practice in England for 6 months or more.  The sample, in effect recruited from the 
general population, are asked a wide range of questions including self-reported EQ-5D-5L.  We used 
data from two years: 2013 (the first time EQ-5D-5L was included in the survey), and 2015 (the last year 
with data collection in the summer and winter).* 
The analysis was conducted at the level of EQ-5D-5L states. First, the states were ranked from the most 
frequently observed to those with no observations. Second, the ranks at which different levels of a given 
dimension first appeared were analysed. Third, the frequencies of all two-way contrasting and non-
contrasting combinations were cross-tabulated. Thus, we identify two kinds of two-way combinations 
that characterise prevalence-based implausibility: those that are the least frequently reported; and 
those that are the most common amongst states that are never observed.  These need not be 
contrasting combinations. 
 
2.2 Stage 2: Gauging the effect of different exclusion strategies in DCETTO  
 
In Stage 2, in order to explore the effect of removing rare state from a design, we re-modelled  EQ-5D-5L 
valuation data that used DCE-with-duration (DCETTO), by systematically excluding observations from 
                                                             
*EQ-5D-5L is coded as five different questions, and the publicly available version of the dataset does not allow 
building the EQ-5D-5L profile.  Therefore, for this analysis, access to the individual data was applied for to NHS 
England. 
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ĐŚŽŝĐĞƚĂƐŬƐƚŚĂƚŝŶĐůƵĚĞĚŚĞĂůƚŚƐƚĂƚĞƐŽĨǀĂƌǇŝŶŐƉůĂƵƐŝďŝůŝƚǇ ?^ĞĐŽŶĚĂƌǇĚĂƚĂĨƌŽŵƚŚĞ ?&ƵƌƚŚĞƌ
Exploration of DCE with duration to value EQ-5D- ?> ? ?&s ?14 project were used, which had included 
substantially more choice tasks than were required to estimate main effects, and enabled us to drop 
some tasks without compromising the integrity of the experimental design.    
 
The FEDEV study was conducted online with a representative sample of the UK general population. The 
valuation data in this study is a subset of the FEDEV dataset, based on DCETTO tasks that were designed 
using non-informative (zero) priors, and administered to 800 respondents. The design included 120 
health profile pairs, where each profile comprises an EQ-5D-5L state and one of six duration levels 
ranging from 0.5 to 10 years. The pairs were selected using a swapping algorithm implemented in the 
DCE design software Ngene,15 based on minimising the D-error. Each respondent completed 10 choice 
tasks from the underlying design.14  
 
The analysis re-estimated the DCETTO models based on conditional logit regressions, which estimate 
utility decrements for each severity level of each dimension.16 The coefficients on the latent scale were 
then anchored onto a scale with 1 for full health and 0 for being dead, producing unanchored and 
anchored sets of coefficients. This was repeated by excluding data generated from certain choice tasks.   
 
The original FEDEV experimental design had 120 choice tasks, to enable exploration of interactions 
between duration and dimension severity level, and is substantially larger than the minimum number of 
choice tasks required for estimating the main effects required for this study, with 21 parameters. We 
were consequently confident that, while excluding some tasks would impact the precision of estimates 
(d-efficiency), it would not impact the statistical identification of unbiased parameter estimates, 
particularly using a design with zero (non-informative) priors where two-way combinations should 
appear a similar number of times. However, since there is a limit to the number or combination of tasks 
that could be removed, we checked the experimental design properties of each selection of tasks for 
important correlations and statistical properties using Ngene.15 
 
Building on the original experimental design, we developed four treatment datasets dropping 
observations from the source data depending on the definition of implausible states to be excluded. It 
would not be appropriate to compare these treatments directly to the full model, since that would 
confound the effect of removing specific observations with the effect of removing any observations.  
Therefore, we created comparator datasets that excluded similar combinations of levels at random over 
multiple draws to reduce bias in comparisons. Table 1 summarises the models used in Stage 2, 
consisting of four different treatments and three comparators. 
 
[PLEASE INSERT TABLE 1 HERE] 
 
The first two treatment models (T1 and T2) were generated based on criteria of perceived implausibility 
proposed for EQ-5D-3L by Dolan1 and Viney et al.9,11 We adapt their two-way contrasting combinations 
to the EQ-5D-5L and re-define them as one dimension with severe or extreme problems (level 4 or 5) 
combined with another dimension with no problems (level 1). For comparability, the third and fourth 
treatment models (T3 and T4) were based on data that excluded observations arising from the same 
number of two-way combinations as the previous models (i.e. four combinations), but based on 
combinations that were empirically identified as the least prevalent in Stage 1. T3 removed the four 
least prevalent two-way combinations amongst self-reported states, while T4 removed the four most 
common two-way combinations amongst never-reported states.   
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Comparator model 1 (C1avg) removed observations from the full dataset based on four randomly 
selected two-way combinations from the set of all possible two-way combinations. Given the random 
nature of the exercise, any result will be subject to random error. Therefore, 100 models were estimated 
based on random draws, and their parameter values averaged. Since treatment models 1 and 2 
removed observations involving two-way contrasting combinations, this may influence the experimental 
design in a systematically different way from comparator model 1.  Comparator models 2 (C2avg) 
excluded observations from the full dataset if they concerned at least one of four two-way combinations 
chosen randomly from the set of 40 two-way contrasting combinations.  This is repeated 100 times and 
the anchored parameter values are averaged. Comparator model 3 (C3) does not exclude any choice 
tasks, and produces a single comparator model using the full dataset. 
 
A total of four treatment models and 201 comparator models were estimated. Predicted values for the 
three most frequently self-reported states with problems in at least two dimensions were estimated 
from anchored parameters to each model, along with values for more plausible states across the range 
of severity (22222, 33333, 44444, and 55555).  A series of further descriptive analyses compare across 
the designs and the estimated parameters in order to distinguish between the effect of removing 
specific observations and that of removing random observations. 
 
 
 
3. Results 
 
3.1 Stage 1: Descriptive analysis 
The GP Patient Survey dataset included 1,639,453 individuals, distributed across 2,707 unique EQ-5D-5L 
health states.  This covers approximately 87% of all possible health states, leaving 418 health states that 
were not reported in our sample. About one third of the respondents reported being in the best health 
state (11111). The three most prevalent states (11111, 11121, 11112) cover just over 50%, and the 33 
most prevalent states cover just over 80% of the observations (see Table 2). Among the 33 most 
prevalent states only one includes SC2, while 27 include PD 2 or worse. None of the 33 most prevalent 
states includes levels 4 or 5. About half of the observed states are reported by less than 0.1% of the 
sample (<1,640).  
[PLEASE INSERT TABLE 2 HERE] 
Table 3 tabulates the overall frequencies of the different levels by dimension, with varying patterns 
across the dimensions. Problems in SC are the rarest, while problems in PD are the most prevalent.  
Furthermore, the prevalence of levels 4 or 5 in MO, UA and PD (ranging from 5.7-7.1%) is relatively 
higher than the prevalence of levels 4 or 5 in SC (2%) and AD (3%). 
[PLEASE INSERT TABLE 3 HERE] 
Table 4 shows select results of cross-tabulations of the frequencies of all two-way combinations (full 
results are in Appendix Section A). When one dimension is fixed at level 1 the prevalence of a particular 
two-way combination rapidly decreases with increasing severity of the other dimension. Hence, 
contrasting combinations of level 1 with levels 4 or 5 are less prevalent than non-contrasting 
combinations between levels 2 and 3. It also appears that non-contrasting combinations of closer levels 
are relatively more prevalent. Therefore, these results support the approach, to operationalise 
implausible states as two-way contrasting combinations between level 1 with levels 4 or 5. This insight 
  
7 
holds when we look at the distribution of two-way combinations amongst the 418 states that are never 
self-reported (Appendix Section B). 
 
[PLEASE INSERT TABLE 4 HERE] 
In terms of the implausibility of the states, all 250 possible two-way combinations are observed in the 
dataset. Nevertheless, some of these are extremely rare: e.g. only 122 individuals self-report having SC4 
alongside UA1 (viz. less than 0.01% of the sample).  The two-way combinations excluded in Viney et al.9 
(MO4/5xUA1; MO4/5xSC1) are not the least frequent combinations. However, a two-way combination 
proposed by Dolan1 and adapted for the EQ-5D-5L (SC4/5xUA1) is one of the 10 least frequently self-
reported two-way combinations. Looking at the two-way combinations that make up the 418 
unobserved states, the same is true: SC4/5 with UA1 are among the 11 most common combinations of 
unobserved states. Furthermore, AD4/5xUA1 and PD5xUA1 are more common amongst the unobserved 
EQ-5D-5L profiles than the four combinations proposed by Viney et al.9 
These distributions informed the selection criteria for treatment models T3 and T4 in Stage 2. Treatment 
model T3 removes the least prevalent of the two-way combinations among all observed health states.  
These are: SC4xUA1, SC4xUA2, SC5xUA2 and SC3xUA1. Treatment model T4 removes the two-way 
combinations that appeared most often amongst those 418 health states that were never reported in 
the dataset. These are: SC4xUA1, PD5xUA1, AD5xUA1 and AD4xUA1.  Across the two approaches, only 
SC4xUA1 is included in both treatments (and T1).   
 
3.2 Stage 2: Re-modelling the DCETTO  dataset 
Excluding choice sets based on the Dolan1 criteria (T1) resulted in the removal of responses from 30 
choice sets (leaving responses from 90). The design properties were analysed, and the highest 
correlation between two-way combinations was below 0.3. The corresponding number of choice sets 
included for T2 (exclusion based on the Viney et al.9 criteria), T3 (exclusion based on observed states 
from Stage 1) and T4 (exclusion based on unobserved states from Stage 1) are 86, 84 and 90, and for all 
correlations remained low (below 0.3) and no other statistical issues in the designs are found. This 
indicates that the exclusion of the choice sets does not impact the robustness of consequent designs for 
the statistical identification of parameter estimates.  For further descriptive analyses of the designs and 
parameters, see Appendix Sections C to E. 
 
Figure 1 presents the anchored coefficients of the DCETTO models.  All the plots are expected to be non-
positive and downward sloping.  This is not always the case, however, and reversed orderings (with the 
implication that utility improves as severity increases) are observed, between levels 2 and 3: for MO (T1, 
T2, T4, C2avg), SC (T1, T4), PD (T3, C1avg, C2avg, C3), and AD (all models).  The coefficient decrements 
for the UA dimension are monotonic. 
[PLEASE INSERT FIGURE 1 HERE] 
Visual inspection of the plots suggest comparator models C1avg and C3 are consistently very close to 
each other - since C3 uses the full dataset while C1avg is based on a random subset of those 
observations, the gap between C1avg and C3 can be interpreted as the magnitude of the effect of 
randomly excluding tasks associated with four two-way combinations from the study design. Similarly, 
the gap between C2avg and C3 represents the effect of randomly excluding tasks associated with four 
two-way contrasting combinations. These three plots suggest that PD and AD are more robust than the 
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other dimensions. The other plots are consistently further away from C3, indicating that there is an 
excess effect beyond the gaps observed for C1avg and C2avg. The plots for T1 and T4 are close to each 
other and tend to be shallower than the others.  Across the models, it appears that UA is the most 
sensitive to the removal of different states, followed by AD.  For example, while the models have 
different anchored coefficients for MO5, SC5 and PD5, all models agree on their relative ranking  W 
however, the models disagree on which of UA5 and AD5 is worse.  Across the dimensions and levels, 
there is no particular curve that is consistently above or below C1avg and C3.  For example, the curves 
for C1avg and C3 mostly below the others for MO, mostly above the others for UA, and mixed with the 
rest for SC, PD and AD.  This means that there will be no consistent patterns across the predicted values 
of the different models. 
Figure 2 plots the predicted values of seven select states across the different models. Three of them are 
the most prevalent self-reported states with problems in at least two dimensions, identified in Step 1 
(11122 is the 4th, 21221 is the 5th, and 21231 is the 10th most prevalent state) and jointly cover 7.5% of 
all observations.  The remaining four are the states with the same level for each dimension (22222, 
33333, 44444 and 55555), which jointly cover 0.52% of all observations.  All anchored coefficients are 
taken at face value, including where they are disordered. The predicted values from all models are very 
similar to each other for state 11122, but less so for the other states. As would be expected from Figure 
1, the plots from the comparator models (C1avg, C2avg and C3) for the seven states are very similar to 
each other. Conversely, the treatment models deviate from these comparator models, but there seems 
to be no consistent pattern across the treatment models.  Predicted values from T3 and T4, both of 
which use evidence-based criteria of implausibility, are not similar to each other, and in fact, the 
predicted values from T4 are much more similar to those from T1, which uses a judgement-based 
criterion of implausibility.  
[PLEASE INSERT FIGURE 2 HERE] 
 
4. Discussion 
 
This paper has attempted to introduce some systematic evidence for the treatment of so-called 
implausible states into an area of health state valuation, where practice has been dominated by 
judgement (and precedents) with little empirical basis.  The analysis raises a number of questions that 
require further consideration. 
භ tŚĂƚĚŽǁĞŵĞĂŶďǇƚŚĞƚĞƌŵ “ŝŵƉůĂƵƐŝďůĞ ? ? 
In this paper, we have introduced a distinction between difficult-to-imagine states (a matter of 
perception or judgement of survey respondents) and rare states (a factual matter). We then explored 
the latter.  At a conceptual level, rare states encompass two further possibilities. One is that some states 
are extremely rare but if the sample size were large enough, all 3,125 EQ-5D-5L states would eventually 
be self-reported. This possibility cannot be ruled out since we observe all two-way combinations in the 
self-report data.  The second is that some extremely rare states involve combinations that are inherently 
not possible and no sample, however large, would include these states - unless self-reported in error.  
However, this scope for error, where people misreport their own health, makes these two possibilities 
practically non-distinguishable.  For example, in our dataset of 1.6 million respondents, there are 274 
states with just one respondent reporting that state, and some of these may be due to measurement 
error; but we cannot say for certain. We do, however, suggest that future research in this area does not 
conflate these concepts and propose to distinguish between: states that are difficult to imagine 
(independently of their actual prevalence); states that are very rare (which may or may not be observed 
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in a sample of finite observations); and states that are physiologically impossible (but which may still be 
self-reported in error).  Using this terminology, this study reports on an empirically identified set of rare 
EQ-5D-5L states, and contrasts this with the perceived implausible states established in the established 
literature. 
 
භ Why not ask survey respondents which states are difficult to imagine? 
The ideal prospective study to decide which states are difficult to imagine would ask general public 
respondents to score all 3,125 states on how difficult it is for them to imagine the health state. In the 
absence of this data, researchers have traditionally avoided using certain states in valuation studies 
based on their own judgement.  The two main disadvantages of this approach are: first, different people 
may find different states difficult to imagine, and there is no guarantee that the remaining states are 
accepted as imaginable by all respondents; and second, the effect of avoiding those states from the 
valuation is not known.  
 
Recently, Yang et al.17 asked medical students to indicate the perceived plausibility of each of the 3,125 
possible EQ-5D-5L states but did not provide an explicit definition of implausibility. One of their findings 
was that, while variation in levels across dimensions of a state increased perceived implausibility, there 
was little agreement over which states were perceived as the least plausible. 
 
However, a different possibility that this paper contributes to might be to examine how prevalent 
different states actually are, remove those from the design, and explain to respondents that while some 
states in the design may seem unlikely, all those states have been self-reported by a general public 
sample.  Furthermore, since the effect of removing various states from valuation designs are not known, 
we compare the effects of two of the most established sets of implausible states in the literature, and 
our evidence-based sets of rare states. 
 
භ Why use general population datasets for Stage 1? 
This analysis used a dataset with self-reported health of the general population. One may question 
whether general population datasets cover a narrower range of EQ-5D-5L states than some patient 
datasets arising from trials or observational studies would.  For example, Devlin et al (2010)18 has 
analysed a heterogeneous patient and general public dataset and found that 161 of the 243 EQ-5D-3L 
states were not self-reported. The justification for carrying out this analysis on a general population 
dataset is that when members of the public are surveyed in health state valuation studies, the range of 
health states that they can typically imagine is more likely to come from their community (which 
includes people who are ill). While general population datasets can claim to represent health states in 
the general community, patient datasets cannot. Moreover, since the dataset used in this analysis is 
very large, and it is likely it includes individuals who would be eligible in various patient surveys and trial 
studies. 
 
Furthermore, the analysis using general population data has another uƐĞĨŽƌĚĞƐŝŐŶŝŶŐ “ĞǆƉĞƌŝĞŶĐĞ-
ƵƚŝůŝƚǇďĂƐĞĚǀĂůƵĞƐĞƚƐ ?19 W21 - studies where members of the public are asked to report and value their 
own current health state. The data are then econometrically modelled, as in conventional health state 
valuation studies, to generate a population value set. One technical challenge associated with such an 
exercise is the inefficiency associated with the highly skewed distribution of health states observed 
amongst the general population.  Across different countries, about a third of the general population self-
report full health using EQ-5D-5L22 W24 and around a half self-report full health in EQ-5D-3L.25,26 The 
prevalence of health states in the general population reported in this study can inform the design of 
such studies, to predict the number of people necessary either to be screened or recruited in order to 
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observe a sufficient range of health states to make these models valid. 
 
භ Why operationalise implausibility in terms of two-way contrasting combinations? 
The health state valuation literature since MVH8 and Dolan1 to Viney et al.9,11 has operationalised 
perceived implausible states in terms of two-way contrasting combinations (also see Jakubczyk and 
Golicki,12 Lim et al.27 or Bagust28).  However, there are three things to note. First, the dataset used in 
Stage 1 includes all 250 two-way combinations, so arguably none of these are impossible. Second, 
notwithstanding this, around 13% (423) of all possible EQ-5D-5L states remain unobserved and thus 
potentially impossible after 1.6 million individuals being surveyed. Third, the least prevalent two-way 
combinations are not necessarily contrasting combinations.  These suggest that if the aim is to remove 
rare states from health state valuation, dropping a handful of two-way contrasting combinations is 
unlikely to be the most efficient way.  On the other hand, we have operationalised rare/impossible 
states in terms of two-way combinations in two approaches based on evidence: the four least prevalent 
two-way combinations amongst self-reported states (T3) and the four most common two-way 
combinations amongst never-reported states (T4).  Unlike the combinations used in the previous 
literature, some of these are non-contrasting combinations.  We show that these two approaches result 
in different combinations, and they have different effects on predicted health state values.   
 
භ How to select the choice tasks to remove? 
Using Dolan1 and Viney et al.9 as templates, we used selection criteria based on four two-way 
combinations in EQ-5D-5L.  However, this does not control for the number of choice tasks for which 
observations are removed from the re-estimation process.  For example, while T2 excludes 34 of the 120 
choice sets and the conditional logit regression model has 5,874 observations, T3 excludes 24 choice 
sets and the model has 6,396 observations. Furthermore, C3 uses the full sample, with 120 choice sets 
and 8,020 observations. Two alternatives might have been either (a) to control for the number of choice 
tasks to remove from the re-estimation; or (b) to control for the number of states to be removed.  While 
these would allow a more like for like comparison of the re-estimation results, the generation of the 
comparator models would be substantially more complex.  Furthermore, since C1avg and C3 have very 
similar results, the estimates appear to be driven largely by what is dropped from the models rather 
than the volume of what is dropped. 
 
භ What should health state valuation studies do about difficult-to-imagine states? 
Health state valuation studies have either identified perceived implausible states based on judgement 
and removed or avoided them from the study design, or ignored the matter altogether.  Our findings 
suggest that removing different states from a DCETTO health state valuation design because of 
judgement-based or evidence-based implausibility will result in different tariff values.  An unexpected 
finding is that the two evidence-based criteria for rare states (T3 and T4) have different effects. Results 
from the further analyses reported in the Appendix suggests that some of the change in parameter 
estimates may be due to the exclusions from the initial designs itself. However, there appears to be an 
excess effect attributable to the exclusion of health states that are rare and/or perceived implausible. 
Given this, and the findings from Yang et al.,17 that there is little agreement across medical students on 
the imagined plausibility of different EQ-5D states, we believe that it is premature to exclude two-way 
combinations from choice designs to address the concern that respondents may feel some states are 
difficult to imagine.  Instead, research might focus on (1) the main factors that make stylised states 
difficult for members of the public to imagine and (2) how best to inform respondents that all states 
used in the survey have been self-reported by the general population, however unlikely they may 
appear. 
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භ What are strengths and limitations of this study? 
To our knowledge, this is the first study to examine the prevalence of different EQ-5D-5L health states in 
the general population, putting forward an evidence-based set of rare states. In order to achieve the 
large self-report dataset necessary for this exercise, we pooled two structurally equivalent waves of the 
GPPS comprising 1.6 million observations. However, the great majority of respondents (80%) 
concentrated in only 33 health states significantly limits the sample size available for the analysis 
conducted in stage 1. 
 
To explore the effects of excluding implausible states of varying definitions on the modelling of DCETTO 
tariffs we exploited a secondary health state valuation dataset. Ideally, a future study may address this 
topic prospectively, focussing on comparative experimental designs, which include and exclude (by 
varying definitions) implausible states, while preserving important design features. However, for the 
time being, re-analysing existing data is an efficient use of resources to first explore this topic. 
 
5. Conclusion 
 
This paper challenges the existing litĞƌĂƚƵƌĞŽŶŚĞĂůƚŚƐƚĂƚĞƐƚŚĂƚĂƌĞĐŽŶƐŝĚĞƌĞĚ “ŝŵƉůĂƵƐŝďůĞ ?ŝŶƚŚĞ
context of health state valuation.  The literature has operationalised implausible states in terms of two-
way contrasting combinations for EQ-5D. However, we find that all 250 two-way combinations of EQ-
5D-5L are actually observed in a large self-report dataset of the general population, and therefore there 
appears to be no physiologically impossible combinations. We also identify health states that have not 
previously been discussed as implausible but are rarer than those that have, some of which are non-
contrasting combinations. Importantly, we find that removing different health states from a valuation 
study may lead to value sets with potentially different characteristics, but that this will depend on the 
criterion of implausible states. Without empirical evidence of difficult-to-imagine states, we recommend 
that valuation studies of EQ-5D do not routinely remove health states from DCETTO designs. Research 
should also focus on how best to communicate with study participants about valuing difficult-to-imagine 
states. 
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TABLES 
 
Table 1:  Summary of models 
 Criterion Which four 2-way interactions 
to drop 
Dropped interactions Number of 
choice tasks 
used in Stage 2 
T1 Dolan As specified in Dolan (1997) MO4/5 x UA1;  
SC4/5 x UA1 
90 
T2 Viney As specified in Viney et al (2011) MO4/5 x UA1;  
MO4/5 x SC1 
86 
T3 Empirically 
reported 
Four least prevalent in reported 
health states in Stage 1 
SC4 x UA1;  
SC4 x UA2;  
SC5 x UA2;  
SC3 x UA1 
84 
T4 Empirically 
unreported 
Four most common in 
unreported health states in 
Stage 1 
SC4 x UA1;  
PD5 x UA1;  
AD5 x UA1;  
AD4 x UA1  
90 
C1 Random Random four from all possible 
interactions 
Average of 100 draws Mean approx. 
91 
C2 Random/40 Random four from the 40 
contrasting interactions 
Average of 100 draws Mean approx. 
92 
C3 Do nothing Do not drop anything n/a 120 
Note: M - Mobility; SC - Self-Care; UA - Usual Activities; PD - Pain/Discomfort; AD - Anxiety/Depression; 
The attached number per dimension refers to the corresponding severity level in that dimension; e.g. 
MO4 x UA1 refers to a health state with severe mobility problems and no problems in usual activities. 
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Table 2:  Frequencies of the 33 most prevalent EQ-5D-5L states 
EQ State Rank Observed 
prevalence 
Share Cumulative 
share 
11111 1 593,664 36.21% 36.21% 
11121 2 201,238 12.27% 48.49% 
11112 3 85,526 5.22% 53.70% 
11122 4 66,014 4.03% 57.73% 
21221 5 38,339 2.34% 60.07% 
21121 6 37,814 2.31% 62.37% 
11131 7 31,711 1.93% 64.31% 
11221 8 27,031 1.65% 65.96% 
11113 9 25,692 1.57% 67.52% 
21231 10 18,345 1.12% 68.64% 
21222 11 17,006 1.04% 69.68% 
11123 12 15,078 0.92% 70.60% 
11222 13 13,940 0.85% 71.45% 
31331 14 13,347 0.81% 72.26% 
11132 15 11,228 0.68% 72.95% 
21122 16 10,577 0.65% 73.59% 
31231 17 10,334 0.63% 74.23% 
21232 18 10,093 0.62% 74.84% 
21131 19 9,468 0.58% 75.42% 
21111 20 8,776 0.54% 75.95% 
11231 21 8,765 0.53% 76.49% 
31221 22 6,877 0.42% 76.91% 
31332 23 6,819 0.42% 77.32% 
11211 24 6,415 0.39% 77.71% 
11133 25 5,785 0.35% 78.07% 
11232 26 5,077 0.31% 78.38% 
  
16 
31232 27 4,880 0.30% 78.67% 
11223 28 4,493 0.27% 78.95% 
21211 29 4,317 0.26% 79.21% 
21223 30 4,296 0.26% 79.47% 
31131 31 4,267 0.26% 79.73% 
31333 32 4,209 0.26% 79.99% 
32332 33 4,180 0.25% 80.25% 
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Table 3:  Overall frequencies of levels by dimensions 
Dimensions and levels Freq. Percent Cum. 
Mobility  1 1,153,397 70.35 70.35 
2 227,757 13.89 84.24 
3 150,365 9.17 93.42 
4 95,655 5.83 99.25 
5 12,279 0.75 100 
Self-care 1 1,454,836 88.74 88.74 
2 84,281 5.14 93.88 
3 66,839 4.08 97.96 
4 23,118 1.41 99.37 
5 10,379 0.63 100 
Usual Activities 1 1,144,815 69.83 69.83 
2 254,141 15.5 85.33 
3 146,500 8.94 94.27 
4 64,210 3.92 98.18 
5 29,787 1.82 100 
Pain/Discomfort  1 760,823 46.41 46.41 
2 503,078 30.69 77.09 
3 259,870 15.85 92.94 
4 94,738 5.78 98.72 
5 20,944 1.28 100 
Anxiety/Depression 1 1,124,379 68.58 68.58 
2 323,255 19.72 88.3 
3 142,460 8.69 96.99 
4 33,631 2.05 99.04 
5 15,728 0.96 100 
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Table 4(a):  Cross-tab of frequencies of respondents at different levels of mobility and self-care. 
Self-Care 
 
Mobility 
1 2 3 4 5 Total 
1 1,143,228 6,911 2,244 505 509 1,153,397 
2 199,003 23,619 3,937 629 569 227,757 
3 88,432 33,159 25,962 2,048 764 150,365 
4 22,108 19,600 33,063 17,934 2,950 95,655 
5 2,065 992 1,633 2,002 5,587 12,279 
Total 1,454,836 84,281 66,839 23,118 10,379 1,639,453 
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Table 4(b):  Cross-tab of frequencies of respondents at different levels of mobility and usual activities.  
Usual Activities  
 
Mobility 
1 2 3 4 5 Total 
1 1,049,134 83,060 16,438 3,210 1,555 1,153,397 
2 78,436 120,365 23,754 3,302 1,900 227,757 
3 13,932 43,595 76,110 12,317 4,411 150,365 
4 1,924 6,565 29,154 43,260 14,752 95,655 
5 1,389 556 1,044 2,121 7,169 12,279 
Total 1,144,815 254,141 146,500 64,210 29,787 1,639,453 
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Table 4(c):  Cross-tab of frequencies of respondents at different levels of self-care and usual activities. 
Usual Activities 
 
Self-Care 
1 2 3 4 5 Total 
1 1,141,250 219,602 76,849 12,395 4,740 1,454,836 
2 2,452 30,931 34,628 12,296 3,974 84,281 
3 433 3,001 32,689 23,853 6,863 66,839 
4 122 226 1,827 14,354 6,589 23,118 
5 558 381 507 1,312 7,621 10,379 
Total 1,144,815 254,141 146,500 64,210 29,787 1,639,453 
 
  
21 
Table 4(d):  Cross-tab of frequencies of respondents at different levels of usual activities and 
pain/discomfort. 
Pain/Discomfort 
 
Usual Activities 
1 2 3 4 5 Total 
1 723,413 342,443 71,433 6,710 816 1,144,815 
2 24,167 131,627 83,765 13,470 1,112 254,141 
3 8,428 21,204 79,700 34,045 3,123 146,500 
4 2,414 4,001 16,308 31,927 9,560 64,210 
5 2,401 3,803 8,664 8,586 6,333 29,787 
Total 760,823 503,078 259,870 94,738 20,944 1,639,453 
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Figures 
 
Figure 1: Comparison of (mean) anchored coefficients. 
 
- T1: Treatment model 1 (exclusion based on the Dolan criteria) 
- T2: Treatment model 2 (exclusion based on the Viney et al criteria) 
- T3: Treatment model 3 (exclusion based on observed states from Stage 1) 
- T4: Treatment model 4 (exclusion based on unobserved states from Stage 1) 
- C1avg: average anchored coefficients from the 100 comparator models (random exclusion) 
- C2avg: average anchored coefficients from the 100 comparator models (random exclusion of 
contrasting interactions), and  
- C3: Comparator model 3 (the full model).
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Figure 2: Comparison of (mean) predicted values of select states. 
 
- T1: Treatment model 1 (exclusion based on the Dolan criteria) 
- T2: Treatment model 2 (exclusion based on the Viney et al criteria) 
- T3: Treatment model 3 (exclusion based on observed states from Stage 1) 
- T4: Treatment model 4 (exclusion based on unobserved states from Stage 1) 
- C1avg: average anchored coefficients from the 100 comparator models (random exclusion) 
- C2avg: average anchored coefficients from the 100 comparator models (random exclusion of 
contrasting interactions), and  
- C3: Comparator model 3 (the full model). 
 
 
